Clinical Trial Update: Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Copanlisib in pediatric patients with relapsed or refractory solid tumors or lymphoma, including neuroblastoma, with Phase 1 and Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Lymphoma in Children
• Neuroblastoma
• Or Refractory Solid Tumors in Children
• Osteosarcoma
• Rhabdomyosarcoma

Drugs mentioned

• Copanlisib (copanlisib)

Snippet

Sponsor: Bayer | Conditions: Relapsed or Refractory Solid Tumors or Lymphoma in Children, Neuroblastoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-12-04